{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:53:26Z","timestamp":1790855606109,"version":"4.1.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.drudis.2019.02.002","type":"journal-article","created":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T12:12:30Z","timestamp":1550059950000},"page":"983-991","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Optimizing intracellular signaling domains for CAR NK cells in HIV immunotherapy: a comprehensive review"],"prefix":"10.1016","volume":"24","author":[{"given":"Giorgio","family":"Zenere","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omalla Allan","family":"Olwenyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6889-4640","authenticated-orcid":false,"given":"Siddappa N.","family":"Byrareddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2937-4685","authenticated-orcid":false,"given":"Stephen E.","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2019.02.002_bib0005","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1182\/blood-2007-09-077438","article-title":"Human natural killer cells","volume":"112","author":"Caligiuri","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2019.02.002_bib0010","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.virol.2012.10.005","article-title":"NK cells controlling virus-specific T cells: rheostats for acute vs persistent infections","volume":"435","author":"Welsh","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.drudis.2019.02.002_bib0015","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.4049\/jimmunol.181.3.1627","article-title":"Priming of natural killer cells by interleukin-18","volume":"181","author":"Chaix","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.drudis.2019.02.002_bib0020","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fimmu.2011.00088","article-title":"Activation of natural killer cells during microbial infections","volume":"2","author":"Horowitz","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.drudis.2019.02.002_bib0025","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1128\/JVI.01975-15","article-title":"Acute viral escape selectively impairs Nef-mediated major histocompatibility complex class I downmodulation and increases susceptibility to antiviral T cells","volume":"90","author":"Weiler","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.drudis.2019.02.002_bib0030","doi-asserted-by":"crossref","first-page":"755","DOI":"10.4049\/jimmunol.161.2.755","article-title":"NK cells can recognize different forms of class I MHC","volume":"161","author":"Ruey-Chyi","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.drudis.2019.02.002_bib0035","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1182\/blood-2012-07-441832","article-title":"Surface CD107a\/LAMP-1 protects natural killer cells from degranulation-associated damage","volume":"122","author":"Cohnen","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2019.02.002_bib0040","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ni1582","article-title":"Functions of natural killer cells","volume":"9","author":"Vivier","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.drudis.2019.02.002_bib0045","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1007\/s10495-007-0095-3","article-title":"The death receptor DR5 is involved in TRAIL-mediated human osteoclast apoptosis","volume":"12","author":"Colucci","year":"2007","journal-title":"Apoptosis"},{"key":"10.1016\/j.drudis.2019.02.002_bib0050","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3109\/10428199909145704","article-title":"Functional CD32 molecules on human NK cells","volume":"35","author":"Morel","year":"1999","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.drudis.2019.02.002_bib0055","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.4049\/jimmunol.141.10.3478","article-title":"Functional and biochemical analysis of CD16 antigen on natural killer cells and granulocytes","volume":"141","author":"Lanier","year":"1988","journal-title":"J. Immunol."},{"key":"10.1016\/j.drudis.2019.02.002_bib0060","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1182\/blood-2005-03-1100","article-title":"Sequential deregulation of NK cell subset distribution and function in acute HIV-1 infection","volume":"106","author":"Alter","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2019.02.002_bib0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003929","article-title":"In vivo administration of a JAK3 inhibitor during acute SIV infection leads to significant increases in viral load during chronic infection","volume":"10","author":"Takahashi","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.drudis.2019.02.002_bib0070","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ebiom.2017.01.034","article-title":"Factors associated with the control of viral replication and virologic breakthrough in a recently infected HIV-1 controller","volume":"16","author":"Walker-Sperling","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.drudis.2019.02.002_bib0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185160","article-title":"HIV exposed seronegative (HESN) compared to HIV infected individuals have higher frequencies of telomeric killer immunoglobulin-like receptor (KIR) B motifs; contribution of KIR B motif encoded genes to NK cell responsiveness","volume":"12","author":"Jackson","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2019.02.002_bib0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006361","article-title":"HIV-1 adaptation to NK cell-mediated immune pressure","volume":"13","author":"Elemans","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.drudis.2019.02.002_bib0085","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1097\/QAD.0b013e3282ffde7e","article-title":"A combined genotype of KIR3DL1 high expressing alleles and HLA-B*57 is associated with a reduced risk of HIV infection","volume":"22","author":"Boulet","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.drudis.2019.02.002_bib0090","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/QAD.0b013e3282f56b23","article-title":"Increased proportion of KIR3DS1 homozygotes in HIV-exposed uninfected individuals","volume":"22","author":"Boulet","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.drudis.2019.02.002_bib0095","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ng934","article-title":"Epistatic interaction between KIR3DS1 and HLA\u2013B delays the progression to AIDS","volume":"31","author":"Martin","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.drudis.2019.02.002_bib0100","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/ng2035","article-title":"Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1","volume":"39","author":"Martin","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.drudis.2019.02.002_bib0105","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.virol.2010.05.014","article-title":"MHC class I chain-related protein A shedding in chronic HIV-1 infection is associated with profound NK cell dysfunction","volume":"406","author":"Nolting","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.drudis.2019.02.002_bib0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006361","article-title":"HIV-1 adaptation to NK cell-mediated immune pressure","volume":"13","author":"Elemans","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.drudis.2019.02.002_bib0115","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1073\/pnas.0409872102","article-title":"Characterization of CD56\u2212\/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals","volume":"102","author":"Mavilio","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2019.02.002_bib0120","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/s41467-018-03618-w","article-title":"Transcriptomic signatures of NK cells suggest impaired responsiveness in HIV-1 infection and increased activity post-vaccination","volume":"9","author":"Costanzo","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drudis.2019.02.002_bib0125","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1182\/blood-2009-11-253286","article-title":"CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells","volume":"116","author":"Juelke","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2019.02.002_bib0130","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.virol.2010.05.014","article-title":"MHC class I chain-related protein A shedding in chronic HIV-1 infection is associated with profound NK cell dysfunction","volume":"406","author":"Nolting","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.drudis.2019.02.002_bib0135","doi-asserted-by":"crossref","first-page":"899","DOI":"10.3389\/fimmu.2018.00899","article-title":"Complement-opsonized HIV-1 alters cross talk between dendritic cells and natural killer (NK) cells to inhibit NK killing and to upregulate PD-1, CXCR3, and CCR4 on T cells","volume":"9","author":"Ellegard","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.drudis.2019.02.002_bib0140","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/aps.2017.125","article-title":"Chimeric antigen receptor (CAR)-transduced natural killer cells in tumor immunotherapy","volume":"39","author":"Hu","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.drudis.2019.02.002_bib0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006753","article-title":"Long-term persistence and function of hematopoietic stem cell-derived chimeric antigen receptor T cells in a nonhuman primate model of HIV\/AIDS","volume":"13","author":"Zhen","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.drudis.2019.02.002_bib0150","doi-asserted-by":"crossref","first-page":"11478","DOI":"10.1073\/pnas.94.21.11478","article-title":"Lysis of HIV-1-infected cells and inhibition of viral replication by universal receptor T cells","volume":"94","author":"Yang","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2019.02.002_bib0155","first-page":"467","article-title":"Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infection","volume":"96","author":"Walker","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2019.02.002_bib0160","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1182\/blood.V96.3.785.015k10_785_793","article-title":"Prolonged survival and tissue trafficking following adoptive transfer of CD4\u03b6 gene-modified autologous CD4+ and CD8+ T cells in human immunodeficiency virus-infected subjects","volume":"96","author":"Mitsuyasu","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2019.02.002_bib0165","first-page":"788","article-title":"A Phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy","volume":"6","author":"Mitsuyasu","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2019.02.002_bib0170","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003761","article-title":"Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells","volume":"4","author":"Scholler","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.drudis.2019.02.002_bib0175","doi-asserted-by":"crossref","first-page":"16014","DOI":"10.1038\/mto.2016.14","article-title":"CAR models: next-generation CAR modifications for enhanced T-cell function","volume":"3","author":"Abate-Daga","year":"2016","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.drudis.2019.02.002_bib0180","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.virol.2013.08.002","article-title":"Anti-HIV designer T cells progressively eradicate a latently infected cell line by sequentially inducing HIV reactivation then killing the newly Gp120-positive cells","volume":"446","author":"Sahu","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.drudis.2019.02.002_bib0185","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.4049\/jimmunol.161.6.2791","article-title":"Chimeric receptors providing both primary and costimulatory signaling in T cells from a single gene product","volume":"161","author":"Finney","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.drudis.2019.02.002_bib0190","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.96976","article-title":"Enhancing CAR T cell persistence through ICOS and 4-1BB costimulation","volume":"3","author":"Guedan","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.drudis.2019.02.002_bib0195","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/PPO.0000000000000028","article-title":"4-1BB chimeric antigen receptors","volume":"20","author":"Campana","year":"2014","journal-title":"Cancer J."},{"key":"10.1016\/j.drudis.2019.02.002_bib0200","doi-asserted-by":"crossref","first-page":"458","DOI":"10.4161\/onci.19855","article-title":"OX40 costimulation by a chimeric antigen receptor abrogates CD28 and IL-2 induced IL-10 secretion by redirected CD4+ T cells","volume":"1","author":"Hombach","year":"2012","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.drudis.2019.02.002_bib0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006613","article-title":"Supraphysiologic control over HIV-1 replication mediated by CD8 T cells expressing a re-engineered CD4-based chimeric antigen receptor","volume":"13","author":"Leibman","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.drudis.2019.02.002_bib0210","first-page":"255","article-title":"Nonhuman primate models in AIDS research","volume":"8","author":"Evans","year":"2013","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.drudis.2019.02.002_bib0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006753","article-title":"Long-term persistence and function of hematopoietic stem cell-derived chimeric antigen receptor T cells in a nonhuman primate model of HIV\/AIDS","volume":"13","author":"Zhen","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.drudis.2019.02.002_bib0220","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.3389\/fimmu.2018.02861","article-title":"Therapeutic targeting of HIV reservoirs: how to give T cells a new direction","volume":"9","author":"Yang","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.drudis.2019.02.002_bib0225","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1200\/JCO.2009.24.4590","article-title":"NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia","volume":"28","author":"Rubnitz","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.drudis.2019.02.002_bib0230","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1365-2141.2008.07340.x","article-title":"Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation","volume":"143","author":"Shi","year":"2008","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.drudis.2019.02.002_bib0235","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/bmt.2009.304","article-title":"Generation of donor natural killer cells from CD34(+) progenitor cells and subsequent infusion after HLA-mismatched allogeneic hematopoietic cell transplantation: a feasibility study","volume":"45","author":"Yoon","year":"2010","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.drudis.2019.02.002_bib0240","doi-asserted-by":"crossref","first-page":"16011","DOI":"10.1038\/mto.2016.11","article-title":"Toxicity and management in CAR T-cell therapy","volume":"3","author":"Bonifant","year":"2016","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.drudis.2019.02.002_bib0245","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.ymthe.2017.06.012","article-title":"Engineering natural killer cells for cancer immunotherapy","volume":"25","author":"Rezvani","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.drudis.2019.02.002_bib0250","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1182\/blood-2004-07-2974","article-title":"Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer","volume":"105","author":"Miller","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2019.02.002_bib0255","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3389\/fimmu.2018.00283","article-title":"Chimeric antigen receptor expressing natural killer cells for the immunotherapy of cancer","volume":"9","author":"Mehta","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.drudis.2019.02.002_bib0260","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.4049\/jimmunol.1300313","article-title":"Membrane-type 6 matrix metalloproteinase regulates the activation-induced downmodulation of CD16 in human primary NK cells","volume":"191","author":"Peruzzi","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.drudis.2019.02.002_bib0265","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3389\/fimmu.2015.00195","article-title":"Utilizing chimeric antigen receptors to direct natural killer cell activity","volume":"6","author":"Hermanson","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.drudis.2019.02.002_bib0270","doi-asserted-by":"crossref","DOI":"10.4161\/onci.26527","article-title":"Retargeting NK-92 cells by means of CD19- and CD20-specific chimeric antigen receptors compares favorably with antibody-dependent cellular cytotoxicity","volume":"2","author":"Boissel","year":"2013","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.drudis.2019.02.002_bib0275","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1582-4934.2011.01343.x","article-title":"NK cells engineered to express a GD2-specific antigen receptor display built-in ADCC-like activity against tumour cells of neuroectodermal origin","volume":"16","author":"Esser","year":"2012","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.drudis.2019.02.002_bib0280","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.4049\/jimmunol.155.2.1000","article-title":"Chimeric zeta-receptors direct human natural killer (NK) effector function to permit killing of NK-resistant tumor cells and HIV-infected T lymphocytes","volume":"155","author":"Tran","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.drudis.2019.02.002_bib0285","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1182\/blood-2004-12-4797","article-title":"Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells","volume":"106","author":"Imai","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2019.02.002_bib0290","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/mt.2014.219","article-title":"Selective inhibition of tumor growth by clonal NK cells expressing an ErbB2\/HER2-specific chimeric antigen receptor","volume":"23","author":"Sch\u00f6nfeld","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.drudis.2019.02.002_bib0295","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/leu.2013.279","article-title":"CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo anti-tumor activity against human multiple myeloma","volume":"28","author":"Chu","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.drudis.2019.02.002_bib0300","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.4049\/jimmunol.1400330","article-title":"DAP12-based activating chimeric antigen receptor for NK cell tumor immunotherapy","volume":"194","author":"T\u00f6pfe","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.drudis.2019.02.002_bib0305","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1158\/0008-5472.CAN-12-3558","article-title":"A chimeric receptor with NKG2D specificity enhances natural killer cell activation and killing of tumor cells","volume":"73","author":"Chang","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.drudis.2019.02.002_bib0310","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/357161a0","article-title":"Profound block in thymocyte development in mice lacking p56lck","volume":"357","author":"Molina","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2019.02.002_bib0315","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1146\/annurev.iy.12.040194.003011","article-title":"The role of protein tyrosine kinases and protein tyrosine phosphatases in T cell antigen receptor signal transduction","volume":"12","author":"Chan","year":"1994","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.drudis.2019.02.002_bib0320","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a002279","article-title":"ZAP-70: an essential kinase in T-cell signaling","volume":"2","author":"Wang","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol"},{"key":"10.1016\/j.drudis.2019.02.002_bib0325","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1006\/smim.2000.0205","article-title":"The role of membrane-associated adaptors in T cell receptor signaling","volume":"12","author":"Zhang","year":"2000","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.drudis.2019.02.002_bib0330","doi-asserted-by":"crossref","first-page":"19641","DOI":"10.1074\/jbc.271.33.19641","article-title":"Phosphorylation of SLP-76 by the ZAP-70 protein-tyrosine kinase is required for T-cell receptor function","volume":"271","author":"Bubeck Wardenburg","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"Suppl. 12","key":"10.1016\/j.drudis.2019.02.002_bib0335","article-title":"T cell receptor signal transduction in T lymphocytes","volume":"2012","author":"Gorentla","year":"2012","journal-title":"J. Clin. Cell. Immunol."},{"key":"10.1016\/j.drudis.2019.02.002_bib0340","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1046\/j.1365-2567.2002.01391.x","article-title":"T-cell antigen receptor signal transduction","volume":"105","author":"Cantrell","year":"2002","journal-title":"Immunology"},{"key":"10.1016\/j.drudis.2019.02.002_bib0345","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1091\/mbc.e08-12-1249","article-title":"ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery","volume":"20","author":"Jung","year":"2009","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.drudis.2019.02.002_bib0350","article-title":"Signal transduction during activation and inhibition of natural killer cells","volume":"11","author":"Watzl","year":"2010","journal-title":"Curr. Protoc. Immunol."},{"key":"10.1016\/j.drudis.2019.02.002_bib0355","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1600-065X.2006.00457.x","article-title":"Activation, co-activation, and co-stimulation of resting human NK cells","volume":"214","author":"Bryceson","year":"2006","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.drudis.2019.02.002_bib0360","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/icb.2013.98","article-title":"Natural cytotoxicity receptors and their ligands","volume":"92","author":"Kruse","year":"2014","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.drudis.2019.02.002_bib0365","doi-asserted-by":"crossref","first-page":"173","DOI":"10.21147\/j.issn.1000-9604.2018.02.02","article-title":"Tumor immunotherapy: new aspects of natural killer cells","volume":"30","author":"Li","year":"2018","journal-title":"Chin. J. Cancer Res."},{"key":"10.1016\/j.drudis.2019.02.002_bib0370","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1084\/jem.190.10.1505","article-title":"Identification and molecular characterization of Nkp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells","volume":"190","author":"Pende","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.drudis.2019.02.002_bib0375","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.19.1.197","article-title":"Activating receptors and coreceptors in human natural killer cell-mediated cytolysis","volume":"19","author":"Moretta","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.drudis.2019.02.002_bib0380","doi-asserted-by":"crossref","first-page":"32934","DOI":"10.1074\/jbc.273.49.32934","article-title":"DAP12-mediated signal transduction in natural killer cells","volume":"273","author":"Mcvicar","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2019.02.002_bib0385","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/ni929","article-title":"NKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathway","volume":"4","author":"Billadeau","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.drudis.2019.02.002_bib0390","doi-asserted-by":"crossref","first-page":"956","DOI":"10.2741\/2735","article-title":"Regulation of NK cell activity by 2B4, NTB-A and CRACC","volume":"13","author":"Claus","year":"2008","journal-title":"Front. Biosci."},{"key":"10.1016\/j.drudis.2019.02.002_bib0395","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1146\/annurev.immunol.19.1.657","article-title":"X-linked lymphoproliferative disease: a progressive immunodeficiency","volume":"19","author":"Morra","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.drudis.2019.02.002_bib0400","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/0-387-34132-3_8","article-title":"The adapter 3BP2: how it plugs into leukocyte signaling","volume":"584","author":"Deckert","year":"2006","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.drudis.2019.02.002_bib0405","doi-asserted-by":"crossref","first-page":"4526","DOI":"10.1073\/pnas.072065999","article-title":"Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation","volume":"99","author":"Sivori","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2019.02.002_bib0410","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.4049\/jimmunol.146.5.1571","article-title":"Analysis of Fc gamma RIII (CD16) membrane expression and association with CD3 zeta and Fc epsilon RI-gamma by site-directed mutation","volume":"146","author":"Lanier","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.drudis.2019.02.002_bib0415","doi-asserted-by":"crossref","first-page":"34310","DOI":"10.1038\/srep34310","article-title":"CD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytes","volume":"6","author":"Yeap","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.drudis.2019.02.002_bib0420","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1084\/jem.175.1.203","article-title":"T cell receptor complexes containing Fc epsilon RI gamma homodimers in lieu of CD3 zeta and CD3 eta components: a novel isoform expressed on large granular lymphocytes","volume":"175","author":"Koyasu","year":"1992","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.drudis.2019.02.002_bib0425","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1067\/mai.2002.127562","article-title":"Proteasome-dependent regulation of Syk tyrosine kinase levels in human basophils","volume":"110","author":"Youssef","year":"2002","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.drudis.2019.02.002_bib0430","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/intimm\/4.11.1313","article-title":"Signaling function of reconstituted CD16: zeta: gamma receptor complex isoforms","volume":"4","author":"Vivier","year":"1992","journal-title":"Int. Immunol."},{"key":"10.1016\/j.drudis.2019.02.002_bib0435","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.immuni.2015.02.013","article-title":"Epigenetic modification and antibody-dependent expansion of memory-like NK cells in human cytomegalovirus-infected individuals","volume":"42","author":"Lee","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.drudis.2019.02.002_bib0440","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/intimm\/dxs080","article-title":"Identification of human NK cells that are deficient for signaling adaptor FcR\u03b3 and specialized for antibody-dependent immune functions","volume":"24","author":"Hwang","year":"2012","journal-title":"Int. Immunol."},{"key":"10.1016\/j.drudis.2019.02.002_bib0445","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.4049\/jimmunol.1203034","article-title":"Cutting edge: antibody-dependent memory-like NK cells distinguished by FcR\u03b3 deficiency","volume":"190","author":"Zhang","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.drudis.2019.02.002_bib0450","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063037","article-title":"Engineering T cell function using chimeric antigen receptors identified using a DNA library approach","volume":"8","author":"Duong","year":"2013","journal-title":"PLoS One"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644618304781?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644618304781?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:38:11Z","timestamp":1761223091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644618304781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":90,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S1359644618304781"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2019.02.002","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing intracellular signaling domains for CAR NK cells in HIV immunotherapy: a comprehensive review","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2019.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}